---
figid: PMC10742113__biomolecules-13-01692-g002
figtitle: Comparative signaling pathways of IL-6, PAI-1 and MCP-1
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10742113
filename: biomolecules-13-01692-g002.jpg
figlink: /pmc/articles/PMC10742113/figure/F2
number: F2
caption: Comparative signaling pathways of IL-6, PAI-1 and MCP-1. IL-6, PAI-1 and
  MCP-1 bind to IL-6R/sIL-6R, LRP and CCR2, respectively. Subsequently, JAK2 phosphorylates
  two STAT3 molecules, resulting in STAT3 dimerization, DNA binding and transcription
  of target genes. For instance, in the IL-6 signaling pathway, this leads to SOCS3
  induction which enacts a negative feedback on JAK2/STAT3 signaling. The interaction
  of IL-6 with IL-6R/sIL-6R activates PI3K/Akt and MAPK pathways that induce JNK,
  PTP1B and SOCS3, thus promoting inflammation, oxidative stress, insulin resistance
  and vascular disorder (green). The PAI-1 signaling pathway contributes to insulin
  resistance and suppresses adipogenesis (purple). Via the MCP-1 signaling pathway,
  the dimerized STAT3 activates G proteins, subsequently triggering PI3K/Akt, RAS/RAF/MEK/ERK
  and adenylyl cyclase (AC) pathways. This causes macrophage infiltration and insulin
  resistance (orange)
papertitle: 'Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking
  Obesity and Gut Microbiota Dysbiosis to Target'
reftext: Teva Turpin, et al. Biomolecules. 2023 Dec;13(12).
year: '2023'
doi: 10.3390/biom13121692
journal_title: Biomolecules
journal_nlm_ta: Biomolecules
publisher_name: MDPI
keywords: adipokines | bacterial metabolites | gut microbiota dysbiosis | insulin
  resistance | obesity | vascular disorder
automl_pathway: 0.9172813
figid_alias: PMC10742113__F2
figtype: Figure
redirect_from: /figures/PMC10742113__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10742113__biomolecules-13-01692-g002.html
  '@type': Dataset
  description: Comparative signaling pathways of IL-6, PAI-1 and MCP-1. IL-6, PAI-1
    and MCP-1 bind to IL-6R/sIL-6R, LRP and CCR2, respectively. Subsequently, JAK2
    phosphorylates two STAT3 molecules, resulting in STAT3 dimerization, DNA binding
    and transcription of target genes. For instance, in the IL-6 signaling pathway,
    this leads to SOCS3 induction which enacts a negative feedback on JAK2/STAT3 signaling.
    The interaction of IL-6 with IL-6R/sIL-6R activates PI3K/Akt and MAPK pathways
    that induce JNK, PTP1B and SOCS3, thus promoting inflammation, oxidative stress,
    insulin resistance and vascular disorder (green). The PAI-1 signaling pathway
    contributes to insulin resistance and suppresses adipogenesis (purple). Via the
    MCP-1 signaling pathway, the dimerized STAT3 activates G proteins, subsequently
    triggering PI3K/Akt, RAS/RAF/MEK/ERK and adenylyl cyclase (AC) pathways. This
    causes macrophage infiltration and insulin resistance (orange)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK2
  - IL6
  - SERPINE1
  - IL6R
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - SOCS3
  - AKT1
  - AKT2
  - AKT3
  - PTPN1
  - STAT3
  - CCL2
  - CCR2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - ATP8A2
  - FABP4
  - GTF3A
  - TFAP2A
  - SLC2A4
  - RAS
  - MEK
  - ATP
  - CAMP
  - nucleus
---
